BOSTON Publicis Groupe said it has acquired Pharmagistics, a Somerset, N.J.-based company specializing in healthcare and pharmaceutical sales and marketing services.
The move is designed to boost the Publicis Healthcare Communications Group's position as a leading global specialty network.
"The acquisition of Pharmagistics is an important part of our strategy to diversify our expertise, and it gives us an additional way to take advantage of the tremendous growth of this sector. With over 20 years of experience in the industry, Pharmagistics has proven its capacity to endure and to adapt in order to best respond to client needs," said Publicis CEO Maurice Lévy, in a statement.
The deal comes five weeks after the Paris-based holding company closed on its $1.3 billion acquisition of Boston-based Digitas in order to strengthen its interactive offering.
Financial terms of the Pharmagistics deal were not disclosed.
Pharmagistics offers four key services: distribution of samples and literature to pharmaceutical sales forces, direct marketing solutions (direct-to-practitioner), sample accountability and specialty logistics.
The company, which has 120 employees, will remain a separate unit with its own identity in PHCG.
Bill Pollock, CEO and president of Pharmagistics, said, "Joining Publicis is a critical move for us, as we will now enjoy the strategic support of a truly global network."